Description
Research Overview
PT-141, also known as bremelanotide, is a synthetic melanocortin analogue investigated in research involving melanocortin receptor signalling and central nervous system pathways.
Research Focus
Experimental and clinical research has examined PT-141 in relation to melanocortin receptors, particularly MC3R and MC4R, as well as physiological processes involving sexual response and hypothalamic signalling.
Scientific Context
Human clinical research has investigated bremelanotide in premenopausal women with acquired, generalized hypoactive sexual desire disorder, and the compound has received regulatory approval in the United States for that specific indication.
Important Research Note
Research findings should be interpreted within the specific formulation, population and experimental conditions studied. This AXEN LABS product is supplied for research purposes only and should not be interpreted as a recommendation for human use, treatment, sexual enhancement or any other application.
For research purposes only. Not intended for human or veterinary use.
